Asthma Clinical Trial
Official title:
Improving Asthma Outcomes Through Stress Management
Uncontrolled asthma in at-risk youth responds well to guideline-based therapy when patients
remain adherent to their management plans. Adherence to inhaled corticosteroids (ICS), when
indicated for persistent or uncontrolled asthma, is a critical component of most asthma
management plans, and other self-management practices such as trigger avoidance are similarly
related to improved asthma outcomes. Adherence to self-management practices is mediated by
multiple factors, including psychosocial stress of parents and their children.
A targeted, culturally appropriate intervention to manage psychosocial stress among the
parents of young, African American, and socioeconomically disadvantaged urban children with
asthma who are receiving guideline-based care may improve asthma self-management, and
therefore asthma outcomes.
Our overall aim is to implement and evaluate a highly collaborative, multi-dimensional,
culturally appropriate and community-based asthma intervention to augment existing
guideline-based best practice. The intervention will target the parents of at-risk, urban,
African American youth, and will employ individualized psychosocial stress management and
peer support.
Uncontrolled asthma in at-risk youth responds well to guideline-based therapy when patients
remain adherent to their management plans. Adherence to inhaled corticosteroids (ICS), when
indicated for persistent or uncontrolled asthma, is a critical component of most asthma
management plans, and other self-management practices such as trigger avoidance are similarly
related to improved asthma outcomes. Adherence to self-management practices is mediated by
multiple factors, including psychosocial stress of parents and their children.
A targeted, culturally appropriate intervention to manage psychosocial stress among the
parents of young, African American, and socioeconomically disadvantaged urban children with
asthma who are receiving guideline-based care may improve asthma self-management, and
therefore asthma outcomes.
Our overall aim is to implement and evaluate a highly collaborative, multi-dimensional,
culturally appropriate and community-based asthma intervention to augment existing
guideline-based best practice. The intervention will target the parents of at-risk, urban,
African American youth, and will employ individualized psychosocial stress management and
peer support.
We will conduct a single blind, prospective randomized controlled trial comparing the IMPACT
DC Asthma Clinic's existing intervention of guideline-based clinical care, education, and
short-term care coordination (usual care) to usual care plus parental stress management in a
cohort of up to 200 parent-child dyads of AA youth aged 4-12 years.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|